Botulinum Toxins and Children’s Health
A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Bacterial Toxins".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 3433
Special Issue Editors
Interests: functional urology; neuro-urology; QoL; uro-oncology
Interests: pediatric urology and surgery; stem cells
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Since 1989, when botulinum neurotoxin (BoNT) was licensed for the treatment of strabismus, its use in medicine has become largely widespread, with an increasing range of indications and the addition of new formulations. However, there are still several controversies about the appropriate uses and dosing of this neurotoxin in the pediatric population. Based on a review of the current literature and original papers, the goal of this Special Issue is to provide an update concerning all possible indications (urological, neurological, and any related modalities of administration of BoNT in the pediatric population).
A list of areas/topics of interest include but are not limited to
- Neurourology;
- Urodynamics;
- Pediatric Urology and Surgery;
- Neurology and Neurophysiology;
- Ophtalmology;
- Colonproctology;
- Histology;
- Pharmacology;
- Dentistry;
- Pain;
- Rehabilitation.
Dr. Maria Angela Cerruto
Dr. Luca Giacomello
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatrics
- children
- botulinum
- neurotoxin
- neuro-urology
- neurogenic bladder
- detrusor dyssynergia
- cerebral palsy
- limb spasticity
- strabismus
- torticollis
- dystonia
- sialorrhea
- brachial plexus
- pain
- anismus
- anal fissure
- constipation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
